Drugs / liquor carbonis distillate
liquor carbonis distillate
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT00769184 | Oct 2008 → Apr 2009 | psoriasis | NeoStrata Company, Inc. | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | liquor carbonis distillate | “15% liquor carbonis distillate (LCD) solution” NCT00769184 ↗ |
| Known as | LCD | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00769184 ↗ |
| Known as | Psorent | “A new steroid-free 15% liquor carbonis distillate (LCD) solution (Psorent) was recently found to be more successful than 0.005% calcipotriol cream (Dovonex) at improving and...” NCT00769184 ↗ |
| Modality | Other / unclassified | “non-steroid medication” NCT00769184 ↗ |